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1. INTRODUCTION 
 
1.1. Allergic diseases 
 
In the last 20-30 years, the prevalence of allergic diseases has increased significantly - a trend 
that shows no signs of abating. It is estimated that 600 million people worldwide experience 
allergic rhinitis and 300 million people worldwide have asthma. In Europe allergic diseases, 
such as allergic rhinitis, asthma and eczema are the most common chronic diseases and their 
prevalence is growing. Up to one child among three is affected, and trends indicate that by 
2015, half of all Europeans may be suffering from an allergy. Some allergies may be fatal; 
others seriously compromise the quality of life: over 70% of allergy patients feel limited in 
their daily activities. There is currently no cure for allergy and asthma, which generate costs 
both in treatment and regular health care use (Zuberbier 264-73;Mullol et al. 327-
34;Biedermann and Rocken 534-41). 
 
Mast cells remain at the core of our understanding of allergic inflammation, they contribute to 
many of the initiating and subsequent events in allergic diseases and are thus one of the major 
targets for investigations and therapeutic interventions in allergy (Nauta et al. 354-60). 
 
1.2. Immunobiology of mast cells 
 
1.2.1. Origin and development 
 
Mast cells develop from progenitor cells that in turn arise from uncommitted hematopoietic 
stem cells in the bone marrow. Mast cell progenitors have been described in peripheral blood 
and represent a distinct pool of cells separate from leukocytes or mononuclear cells. Mast cells 
express the receptor c-kit for stem cell factor (SCF), a specific growth factor for mast cells. 
SCF is regarded as a cardinal factor in mast cell biology, after binding to c-kit, it has the 
capacity to induce differentiation, migration and growth of mast cells. Kirshenbaum and 
colleagues (Kirshenbaum 497-+;Kirshenbaum et al. 2333-42) have described CD34+, c-
kit+(CD117+) and CD13- precursors that develop into mast cells. Mast cells deprived of SCF 
undergo apoptosis (Okayama and Kawakami 97-115;Berent-Maoz et al. 2272-78;Moller et al. 
1330-36;Biedermann 99-109).  
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Another mast cell growth factor – interleukin 3 (IL-3) - seems to be crucial for early mast cell 
proliferation in the mouse system (Okayama and Kawakami 97-115;Itakura et al. 803-11). 
 
Mast cells undergo terminal differentiation in tissues. They are widely distributed throughout 
all vascularised organs and are particularly abundant (3000-25000 mast cells/mm3) in 
proximity to environmentally exposed surfaces, e.g. the skin, and in the gastrointestinal and 
respiratory tracts. In these tissues they occur near blood vessels, epithelia, smooth muscles and 
nerves. These mature cells may divide further (Yong 409-24). 
 
1.2.2. Morphology and heterogeneity 
 
Up to 40% of the volume of mast cell is occupied by membrane-enclosed metachromatically 
stained basophilic secretory granules. There are 50 to 500 secretory granules in one mature 
mast cell. Within a given mast cell, these granules are usually of a uniform size, but there is 
variability from cell to cell. Mast cell granules originate from the Golgi apparatus, which is 
responsible for the synthesis and organization of the preformed mediators contained therein 
(Yong 409-24).  
 
Tissue mast cells are highly heterogeneous with great variability in size, granule contents, 
cytokine production and receptor expression. Both in vitro experience and in vivo data suggest, 
that this heterogeneity represents an exquisite developmental sensitivity to local signals 
(Okayama and Kawakami 97-115). Similarly, the maintenance of mast cells within tissues is 
controlled by the local environment, in particular by the production of SCF by stromal cells. 
 
In rodent tissues mast cells are classified into two distinct subtypes: connective tissue mast 
cells, preferentially located in skin, and mucosal mast cells, dominantly found in mucosa, such 
as the intestine (Kitamura, Oboki, and Ito 164-74).  
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1.2.3. Activation and functions 
 
Mast cell activation 
 
Mast cells can be activated in different ways. Stimulation of the mast cell activation, initiated 
either by interaction of the antigen specific antibodies or the antigen with the corresponding 
mast cell receptors, is referred to as immunologic activation. Alternatively, the stimulation, 
induced by substances such as neuropeptides, basic compounds, cytokines, and certain drugs, is 
called nonimmunologic activation. Both immunologic and nonimmunologic stimulations 
produce morphologically similar degranulation events (Fig. I). However, biochemical 
processes preceding the degranulation are different. 
 
  
 
Figure I:Schematic presentation of the different ways of mast cell activation 
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Activation through FcεRI 
 
The classical mast cell activation during inflammatory reaction occurs through the high affinity 
receptor FcεRI. FcεRI is a tetrameric complex, where an extracellular α chain binds the Fc 
portion of immunoglobulin E (IgE), whereas a transmembrane β chain along with disulfide-
linked transmembrane γ chains participate in the signal transduction. Aggregation or so called 
“cross-linking” of IgE molecules bound to FcεRI on mast cells with allergen/antigen (Ag) 
causes mast cell degranulation. The cascade of signal transduction pathways triggers 
solubilization of the granule contents, granule swelling, membrane ruffling, fusion of the 
perigranular and plasma membranes, and, finally, leading to the exocytosis of granule content.  
 
Degranulation of the mouse mast cells can be also triggered by aggregation of the surface-
expressed IgG receptors, FcγRII and FcγRIII. These low-affinity receptors may regulate high-
affinity IgE receptor-mediated activation (Yoshioka et al. 452-61;Bruhns, Fremont, and Daeron 
662-69;Castells 287-92). 
 
Other ways of mast cell activation 
 
Complement-dependent signals are important components of the mechanisms by which mast 
cells are activated during infections. Mast cells express multiple receptors for the complement 
components (anaphylatoxins) C3a, C4a and C5a. These receptors include CD11b (CR3), 
CD11c (CR4), which are up-regulated during systemic mastocytosis, and C5aR. (Soruri et al.). 
 
The TLR (Toll-like receptor) family of pattern-recognition receptors has an important role in 
many host defence mechanisms. Different members of the TLR family are activated by 
pathogen-associated or endogenous proteins. The mast cell uses selected TLRs to respond to 
pathogens. For example, mast cells respond to lipopolysacharide (LPS) through TLR4. In 
contrast, activation by peptidoglycan from gram-positive bacteria and the yeast cell-wall 
component zymosan are mediated through the TLR2 (Fehrenbach et al. 2087-94;Gangloff and 
Guenounou 115-25). 
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 It was demonstrated that a number of cytokines (IL-1, IL-3) cause the release of histamine, 
SCF and macrophage inflammatory protein-1α activate the degranulation of mast cells in vitro 
and in vivo (Lukacs et al. 2262-68). 
 
Dextrans and lectins appear to activate mast cells through a multipotent interaction with the cell 
membrane and a cross-linking of glucose receptors on the membrane. Other compounds that 
can directly activate mast cells include calcium ionophores, substance P (neuropeptide), 
compound 48/80, and drugs such as morphine, codeine and synthetic adrenocorticotropic 
hormone, adenosine and endothelin (Eszlari et al. 267-85;Collins et al. 843-49). 
 
Mast cell functions 
 
Mast cells exert their biological functions almost exclusively by humoral immune mechanisms. 
Nearly all mast cell functions are restricted to the release of mediators (although there are a few 
reports of mast-cell phagocytosis and other non-humoral functions in mice and rats). The array 
of mediators released by mast cells is enormous and explains how mast cells can be involved in 
so many different physiological (Fig. II) and pathophysiological conditions. 
 
 
 
Figure II: Proposed functions of mast cells under normal conditions 
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Physiological mast-cell functions include the regulation of epithelial functions (secretion and 
epithelial permeability), smooth-muscle functions (peristalsis and bronchoconstriction), 
endothelial functions (blood flow, coagulation and vascular permeability), immune functions 
(recruitment and activation of neutrophils, eosinophils and lymphocytes), neuronal functions 
(neuroimmune interactions, peristalsis and pain) and other tissue functions (wound healing and 
fibrosis). The physiological triggers might include growth and other tissue factors, infectious 
agents, neuropeptides, protein antigens and physiochemical conditions, such as a change in pH 
or in osmolarity, FGF, fibroblast growth factor; IL, LTC4, leukotriene C4; PGD2, prostaglandin 
D2; TGF , transforming growth factor- ; TNF, tumour-necrosis factor; TReg cell, CD4+CD25+ 
regulatory T cell; VLA4, very late antigen 4 (Kirchhoff et al. 1591-94). 
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1.3. Mast cells in allergic diseases 
 
It is well established that mast cells mediate the early phase of type I hypersensitivity reactions, 
as well as late-phase reactions that occur facultatively following early-phase reactions, and that 
are thought to cause the recurrent and chronic symptoms (Fig. III). Mast cells participate also 
in hypersensitivity reactions other than type I reactions, such as type IV(Nauta et al. 354-60). 
 
 
 
 
Figure III: Role of mast cells in allergic inflammation 
 
Type I hypersensitivity is characterized by an allergic reaction that occurs immediately 
following contact with the antigen, referred to as the allergen (most common of them are 
animal products, insect sting venoms, foods, drugs, pollens etc). Mast-cell activation by IgE 
cross-linking with allergen requires access of allergen into the tissue and input from the 
adaptive immune system to be effective. Mast-cell activation needs the synthesis of specific 
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IgE by B cells (regulated by IL-4 and IL-13 derived from T helper 2 (TH2) cells and basophils) 
and mast-cell priming by IL-4 for enhanced mediator release(Scholz, Prieschl, and Baumruker 
7-18;Leung 157-67). 
 
Within seconds to minutes after IgE cross-linking, granules in the cytoplasm of the mast cell 
fuse with each other and with the cell surface membrane, ejecting their contents into the 
extracellular milieu. The contents of the granules include histamine, proteoglycans (heparin, 
chondroitin sulfate), a series of neutral proteases, broadly grouped into tryptases, chymases and 
carboxypeptidases, and other enzymes, for example ß-hexosaminidase (so called “preformed” 
mediators). Histamine promotes vascular permeability; proteoglycans provide a scaffold within 
the granule that allows the packaging of proteases; and the neutral proteases cleave proteins 
from matrix and plasma in addition to activating propeptides such as the precursors for IL-1β 
and angiotensin II. The murine mast cell protease 6 also contributes potently to neutrophil 
chemotaxis. Certain subsets of mast cells store TNF within the granules as well, representing 
the body's only source of TNF available for immediate release(Scholz, Prieschl, and 
Baumruker 7-18).  
 
Within minutes of IgE-mediated activation, mast cells begin to generate eicosanoids derived 
from cleavage of arachidonic acid from membrane phospholipids. Important arachidonic acid 
metabolites include the leukotrienes (leukotriene B4 and the cysteinyl leukotrienes), which 
increase vascular permeability, induce vasoconstriction and recruit leukocytes, and 
prostaglandins, including the neutrophil chemoattractant and vasoactive mediator prostaglandin 
D2. 
 
The subsequent release of mast cell mediators induces an early reaction, consisting classically 
of a “wheal and flare” reaction of the skin or the mucosa. 
 
Within hours, a later phase of mast cell activation through IgE becomes evident with the 
induction of new gene transcription and translation, generating a host of cytokines and 
chemokines. IL-3, IL-5, IL-8, TNF, neurotrophin 3 and proteases contribute to the initiation of 
a facultative late-phase reaction by recruiting and activating eosinophils, neutrophils and TH2 
cells, and by interaction with tissue cells such as nerve cells, smooth-muscle cells, endothelial 
cells and the epithelium. Ongoing dysregulation of 
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allergy, but also organ dysfunction, including loss of barrier function and, subsequently, 
increased bacterial translocation. This enables non-specific triggers to access mast cells, 
dendritic cells and other cells. Triggers such as bacterial products, or immunoglobulin 
(fragments) such as monomeric IgE and light chains might perpetuate the inflammatory 
process, even in the absence of allergen (Goksu and Ozdemir 577-88). 
 
Symptoms depend on the form of allergy and allergen responsible for the occurrence of allergy, 
and can vary from mild to fatal. Anaphylaxis is referred to as acute systemic and very severe 
type I hypersensitivity allergic reaction in humans and other mammals, which involves 
particularly the skin, respiratory tract, cardiovascular system and gastrointestinal tract. 
Anaphylactic shock, the most severe type of anaphylaxis, occurs when an allergic response 
triggers a quick release from mast cells of large quantities of immunological mediators leading 
to systemic vasodilation (associated with a sudden drop in blood pressure and hypothermia in 
mice) and edema of bronchial mucosa (resulting in bronchoconstriction and difficulty 
breathing). Anaphylactic shock can lead to death in a matter of minutes if left untreated 
(Przybilla, Ring, and Rueff 1025-31). 
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1.4. Role of ion channels in mast cell function 
 
Role of Ca2+ channels 
 
IgE-dependent activation of mast cells is characterised by an influx of extracellular Ca2+, which is 
essential for subsequent release of both preformed mediators and newly generated autacoids and 
cytokines. 
 
In rodent mast cells there is evidence of Ca2+ influx through non-selective cation channels and 
store-operated channels (SOCs). The SOCs activated following depletion of intracellular Ca2+ 
stores are also known as calcium release-activated Ca2+ channels (CRAC). Previous data has 
shown a close association between Ca2+ influx through CRAC in rat basophilic leukemia (RBL) 
cells, which serve as a model of mucosal mast cells, and both degranulation and arachidonic acid 
metabolism with subsequent secretion of LTC4. (Chang et al. 4622-31;Liu, Groschner, and 
Ambudkar 93-104;Fischer et al. 1255-62). 
 
The pore-forming subunits of SOCs are presented by Orai, a recently discovered family of 
proteins, which consists of three closely conserved cell surface proteins (Orai1–3 or CRACM1-3) 
(Prakriya et al. 230-33;Feske et al. 179-85). Orai interacts with stromal interacting molecule 
(STIM), which acts as an endoplasmic reticulum (ER) Ca2+ sensor, that activates CRAC channels 
when Ca2+ levels in ER stores drop (Mignen, Thompson, and Shuttleworth 703-15;Csutora et al. 
14524-31). Upon calcium store depletion, STIM proteins reorganize from their diffuse positions 
throughout the ER membrane to form discrete points close to the plasma membrane. Activated 
Orai colocalizes with STIM, concentrating calcium influx to the membrane region containing both 
proteins (Oh-Hora and Rao 250-58).  
 
Researchers studying STIM1-deficient mice have found that in mast cells STIM1 is required for 
FcεRI-induced Ca2+ influx, degranulation, activation of the transcription factors NF-κB and 
NFAT, and IgE-dependent anaphylaxis in vivo (Baba et al. 81-88). 
 
In studies exploiting STIM- and CRACM1-deficient mice it has been shown that STIM and 
CRACM1 are required for mast cell FcεRI-induced degranulation, synthesis of lipid mediators, 
cytokine release and IgE-dependent allergic responses in vivo (Vig et al. 89-96). Thus, it has been 
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conclusively demonstrated that the second stage of FcεRI-induced Ca2+ mobilization, which is the 
influx of Ca2+ mediated by STIM1 and CRACM1, is essential for mast cell activation in vitro and 
in vivo (Vig et al. 89-96;Baba et al. 81-88). 
 
Another big group of Ca2+-permeable channels is a family of transient receptor potential (TRP) 
channels. TRP channels are classified by their homology, including members of the 
canonical/TRPC subfamily, melastatin/TRPM subfamily and vanilloid/TRPV subfamily. There is 
an evidence that canonical transient receptor potential channels (TRPCs), which are Ca2+-
permeable nonselective cation channels, may associate with STIM1 and CRACM1 to enhance 
Ca2+ entry (Vig et al. 89-96;Liao et al. 2895-900). 
 
A thermally activated TRPV2 channel has been identified in mouse BMMCs. It is expressed in 
the plasma membrane and since the cells exhibit a rise in cytosolic free Ca2+ and degranulate at > 
50ºC, which is dependent on the presence of extracellular Ca2+, it is appears to be biologically 
active (Stokes et al. 669-83;Stokes et al. 137-47). 
 
A requirement for TRPC5 in addition to STIM1 and CRACM1 for optimal FcεRI-induced Ca2+ 
influx and degranulation has been identified in a RBL-2H3 cell line by using inhibitory RNA. The 
authors speculate, that TRPC5 associates with STIM1 and CRACM1 in a stoichiometric way to 
enhance FcεRI-induced Ca2+ influx and degranulation (Zhao et al. 561-68). 
 
The rate of Ca2+ influx through store-operated channels is also dependent on the membrane 
potential, which is regulated in part by Ca2+-activated nonselective cation channels such as 
TRPM4. Its activation results in an influx of Na+ that depolarizes membrane and limits the driving 
force for Ca2+ entry through CRAC channels in BMMCs. FcεRI-induced degranulation, release of 
leukotrienes and production of TNF, but not IL-6, are higher in TRPM4-deficient BMMCs, and 
TRPM4-deficient mice develop more severe acute (but not late-phase) inflammation during IgE-
mediated passive cutaneous anaphylaxis responses. Accordingly, it has been proposed that 
TRPM4 acts as a ‘molecular brake’ on Ca2+ influx after FcεRI-induced activation of mast cells in 
vitro and in vivo (Mathar et al. 35). 
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Role of K+ and Cl- channels 
 
Mast cells express K+ and Cl- channels which are likely to play an important role in mast cell 
activation responses through their effect on membrane potential (Bradding et al. 614-20;Duffy et 
al. 4261-70).  
 
Mast cells express the intermediate conductance Ca2+ activated K+ channel, KCa3.1 (also known as 
IKCa1 or SK4) (Sausbier et al. 42;Woelbing et al. S1). This channel maintains a negative 
membrane potential during cell activation. Following FcεRI cross-linking, mast cells open KCa3.1 
channels. The negative cell membrane potential generated by the activity of K+ channels enhances 
Ca2+ influx and mediator release due to both the favourable electrical driving force for Ca2+ entry 
and enhanced Ca2+ conductance through SOCs that mediates Ca2+ influx following cell activation 
(Duffy et al. 1653-62). 
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1.5. Role of PI 3-kinase in FcεRI signaling 
 
The phosphoinositide 3-kinases (PI 3-kinases) are a ubiquitously expressed enzyme family that, 
through the generation of phospholipid second messengers, play a key role in the regulation of 
many cellular processes. PI 3-kinases participate in a broad range of signaling processes 
downstream of growth factors, antigens, hormones and adhesion receptors, regulating motility, 
proliferation, survival, glucose metabolism and cytoskeletal organization. They are classified 
into several distinct groups (types I-III), based on their primary structure, mode of regulation 
and substrate specificity. PI 3-kinases principally transduce signals through the catalytic 
generation of phosphatidylinositol (3,4,5)-trisphosphate, PI(3,4,5)P3, and phosphatidylinositol 
(3,4)-biphosphate, PI(3,4)P2, two second messengers that facilitate the recruitment of 
pleckstrin homology domain containing signaling proteins to the plasma membrane (Marone et 
al. 159-85). 
 
Mast cell degranulation following FcεRI aggregation is generally believed to be dependent on 
PI 3-kinase activation. Aggregation of FcεRI leads to the activation of ß subunit-associated 
Lyn, a Src family protein tyrosine kinase (PTK). Activated Lyn phosphorylates tyrosine 
residues in the immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic 
regions of ß and γ subunits. Phosphorylated ß and γ ITAMs recruit Lyn and Syk, respectively. 
Another Src family PTK, Fyn, was also shown to associate with FcεRI and to play a 
complementary role, particularly by activating PI 3-kinase. These PTKs phosphorylate 
numerous targets and activate several signaling pathways, including the PI 3-kinase, 
phospholipase C (PLC) and several MAPK pathways. The activated PLCγ hydrolyzes 
PI(4,5)P2 to D-myo-inositol 1,4,5-trisphosphate, Ins(1,4,5)P3, and diacylglycerol, which 
induce the release of Ca2+ from intracellular stores and the activation of protein kinase C, 
respectively. On the other hand, stimulation of PI 3-kinase results in transient accumulation of 
milimolar levels of PI(3,4,5)P3 and PI(3,4)P2 (Daeron 445-65). These signaling events lead to 
degranulation and cytokine and chemokine production. 
 
Although the involvement of PI 3-kinase in Ag-induced degranulation is established, a clear 
consensus regarding how products derived from the action of PI 3-kinase mediate the cellular 
responses has yet to emerge.  
 
14 
Data from several laboratories propose a role of PI 3-kinase in the regulation of intracellular Ca2+ 
([Ca2+]i) increase in mast cells. Evidence suggests that PI 3-kinase may mediate [Ca2+]i elevation 
via two distinct mechanisms. First, in vitro data indicate that PI(3,4,5)P3 stimulates Ins(1,4,5)P3 
production by activating PLCγ isozymes. This PLCγ activation may be attained directly by 
facilitating membrane translocation or indirectly via Btk. Second, PI 3-kinase may increase [Ca2+]i 
by facilitating Ca2+ mobilization across plasma membranes. This premise was prompted by data 
showing the inhibitory effect of PI 3-kinase inhibitors on Ag-induced Ca2+ response, and is in line 
with the notion that two distinct Ca2+ influx pathways (capacitative vs. non-capacitative) are 
operative in Ag-stimulated RBL-2H3 cells (Lee et al. 581-92;Lee et al. 581-92;Ching et al. 14814-
20). 
 
It is noteworthy that the proposed involvement of PI 3-kinase in the regulation of a non-
capacitative Ca2+ influx pathway is reminiscent of a finding of a PI(3,4,5)P3-sensitive Ca2+ entry 
mechanism in platelets and Jurkat T-cells. Consequently, it is hypothesized that this PI(3,4,5)P3-
sensitive Ca2+ entry is a conserved mechanism that plays a crucial role in the regulation of 
receptor-mediated Ca2+ signaling among these hematopoietic cells. This hypothesis is 
corroborated by data showing the involvement of this PI(3,4,5)P3-mediated Ca2+ influx in FcεRI-
mediated Ca2+ response in RBL-2H3 cells (Djouder et al. 1243-50;Oka et al. 837-46;Fischer et al. 
1255-62). Considering that PI 3-kinase and PLCγ are the downstream effectors of the FcεRI-
mediated tyrosine kinase cascade, it is proposed that these two enzymes act in a concerted manner 
to initiate Ca2+ response to Ag stimulation. In stimulated cells, PI 3-kinase and PLCγ act on the 
mutual substrate PI(4,5)P2 to generate PI(3,4,5)P3 and Ins(1,4,5)P3, respectively, which activate 
Ca2+ channels at different cellular compartments to provide the elevated [Ca2+]i, required for 
optimal physiological responses (Finkelman 506-15;Bradding and Conley 979-83;Duffy et al. 
4261-70). 
 
In other cell types, PI 3-kinase-mediated signaling has been also shown to participate in the 
regulation of ion channels. In cells transfected with the intermediate conductance Ca2+-activated 
K+ channels KCa3.1, PI 3-kinase inhibition significantly decreased channel activity (Srivastava et 
al. 3630-38). 
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Despite the critical role of PI 3-kinase, on the one hand, and Ca- and Ca2+-activated K+ channels, 
on the other hand, the influence of PI 3-kinase on the activity of these mast cell channels and thus 
mast cell function is not fully understood.  
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1.6. Serum- and glucocorticoid-inducible kinases 1 and 3 
 
PI 3-kinase-dependent signaling involves 3-phosphoinositide (PIP3)-dependent kinase PDK1, 
which phosphorylates and thus activates PKB and serum- and glucocorticoid-inducible kinases 1 
(SGK1) and 3 (SGK3) (Lang et al. 1151-78).  
 
SGK1 was originally cloned in 1993 as an immediate early gene transcriptionally stimulated by 
serum or glucocorticoids in rat and mammary tumor cells. Transcription of SGK1 was also shown 
to occur rapidly in response to many agonists like mineralocorticoids (Grahammer et al. R945-
R950;Richards 209-18), follicle stimulating hormone (Richards 209-18;Friedrich et al. 303-07), 
transforming growth factor (TGF- β) (Friedrich et al. 303-07), thrombin (BelAiba et al. 828-36), 
hypertonicity (Klaus et al. 1539-47), high glucose (Boini et al. 2059-66) and neuronal injury or 
excitotoxicity. 
 
SGK1 belongs to the ‘AGC’ subfamily of serine/threonine protein kinases, which include protein 
kinase A (PKA) or adenosine 3’, 5’ monophophate (cAMP)-dependent protein kinase, PKG or 
guanosine 3’, 5’ monophosphate (cGMP)-dependent protein kinase and isoforms of PKC. SGK1 
is present in the genomes of all eukaryotic organisms examined so far, including Caenorhabditis 
elegans, Drosphila, fish and mammals. Structure of SGK1 has been highly conserved through 
evolution like many other protein kinases. 
 
Two other isoforms of SGK1 have been identified in mammals and are named as SGK2 and 
SGK3. The catalytic domains of SGK2 and SGK3 isoforms share 80% amino acid sequence 
identity with one another and with SGK1. 
 
The human gene encoding SGK1 was found in chromosome 6q23. SGK-like gene which encodes 
a protein having predicted amino acid sequence identical to that of human SGK3 was found in 
chromosome 8q12.2. 
 
SGK1 is expressed in humans including the pancreas, liver, heart, lung, skeletal muscle, placenta, 
kidney and brain, but SGK1 is not expressed in all cell types within those tissues. For example, 
SGK1 transcript levels are found high in acinar cells in the pancreas. High transcript levels of 
SGK1 are also found in the distal tubule and collecting duct of the kidney and in thick ascending 
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limb epithelial cells. It expresses most abundantly in liver, kidney and pancreas. As like SGK1, 
SGK3 mRNA is present in all human and murine tissues examined but expression is particularly 
high in the mouse heart and spleen and in the embryons (Lang et al. 1151-78). 
 
SGK3 is identical to the cytokine-independent survival kinase, CISK. The "SGK-like" gene in 
chromosome 8q12.3 encodes a protein which predicted amino acid sequence is virtually identical 
to that of human SGK3. SGK3 is expressed in all tissues tested thus far (Kobayashi et al. 189-97). 
Unlike SGK1, SGK3 is not under transcriptional control of serum and glucocorticoids (Lang et al. 
1151-78). 
 
Neither knockout of SGK3, nor of both, SGK1 and SGK3 leads to a severe phenotype suggesting 
that neither SGK1 nor SGK3 are required for survival. Gene targeted mice lacking functional 
SGK3 have a strikingly delayed hair growth, which has been attributed to apoptosis of 
keratinocytes. Moreover, SGK3 deficient mice have decreased basal intestinal glucose transport 
and a subtle decrease of locomotion (Lang et al. 1151-78;McCormick et al. 4278-88).  
 
To become functional, SGK1 is activated by phosphorylation through a signaling cascade 
including PI 3-kinase and phosphoinositide dependent kinase PDK1 and PDK2/H-motif kinase.  
 
SGK1 and its isoforms have a considerable physiological role through the regulation of 
transporters and ion channels. For instance, they regulate the epithelial Na+ channel, ENaC, the 
voltage-gated Na+ channel, SCN5A, the K+ channels ROMK1, KCNE1/KCNQ1 and Kv1.3 , the 
cation channel TRPV5 (Palmada et al. 175-82;Embark et al. 203-12), the Na+/H+ exchanger 
NHE3 (Sandu et al. G868-G876), the dicarboxylate transporter NaDCT, the glutamate transporters 
EAAT1 (Lang et al. 1151-78), EAAT3 (Rexhepaj et al. 2214-22), EAAT4 (Rajamanickam et al. 
858-66;Bohmer et al. 1242-48) and EAAT5 and the Na+/K+-ATPase (Embark et al. 601-06;Henke 
et al. 370-74). The regulatory activity of SGK1 and its isoforms plays a diverse role in essential 
cell functions such as epithelial transport, excitability, cell proliferation and apoptosis (Lang et al. 
1151-78). 
 
However, it is not known, whether SGK1 and SGK3 participate in the regulation of mast cell ion 
channels and thus in the regulation of mast cell functions. 
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2. AIMS OF THE STUDY 
 
The manifestations of mast-cell-driven allergic reactions are considered to be mainly a 
consequence of the release of pro-inflammatory mediators following Ag-induced aggregation of 
IgE-bound FcεRIs expressed on the mast-cell surface. 
 
Mast cell stimulation involves activation of ion channels, such as Ca2+, K+ and Cl- channels. 
Upon mast cell activation, store-operated and receptor-mediated Ca2+ channels allow the entry 
of Ca2+ into the cell, which triggers exocytosis and thus degranulation. The electrical driving 
force for Ca2+ entry is provided by the cell membrane potential, which is maintained by the 
activity of K+ channels. Accordingly, cell membrane depolarization decreases Ca2+ influx and 
subsequent degranulation. Ca2+-activated K+ channels are critical in this scenario, as 
pharmacological inhibition of these channels disrupts degranulation. 
 
Ion channel activity and function are dependent on PI 3-kinase. Signaling molecules downstream 
of PI 3-kinase include among others SGK1 and SGK3. 
 
The present study has been performed to elucidate the role of PI 3-kinase in the regulation of 
mast cell Ca2+ and Ca2+-activated K+ channels, and thus in modulation of mast cell function. 
Also we aimed at investigating whether the PI 3-kinase-dependent ion channel regulation and 
function of mast cells similarly involves SGK1 and SGK3. Thus, the function of mast cells has 
been studied in gene-targeted mice lacking SGK1 (sgk1-/-) and their wild-type littermates (sgk1+/+), 
and SGK3 (sgk3-/-) and their wild-type littermates (sgk3+/+).  
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3. MATERIALS AND METHODS 
3.1. Chemicals and reagents 
 
Albumin, dinitrophenyl 
(DNP-HSA) Sigma-Aldrich, Munich, Germany 
Allophycocyanin-labelled 
anti-CD117 BD Pharmingen, Heidelberg, Germany 
Anti-DNP IgE, clone SPE-7 Sigma-Aldrich, Munich, Germany 
Apamin Sigma-Aldrich, Munich, Germany 
Clotrimazole Sigma-Aldrich, Munich, Germany 
DMSO Sigma-Aldrich, Munich, Germany 
EGTA Sigma-Aldrich, Munich, Germany 
Fetal bovine serum Hyclone/Perbio, Bonn, Germany 
Fluorescein-isothiocyanate-labelled 
anti-CD34 BD Pharmingen, Heidelberg, Germany 
Fura-2/AM Molecular Probes, Goettingen, Germany 
Iberiotoxin Sigma-Aldrich, Munich, Germany 
Ionomycin Calbiochem, Darmstadt, Germany 
LY-294002 hydrochloride Sigma-Aldrich, Munich, Germany 
PBS GIBCO, Carlsbad, Germany 
Penicilliln/Streptomycin Invitrogen, Karlsruhe, Germany 
Phycoerythrin-labelled 
anti-FcεRI eBioscience GmbH, Frankfurt, Germany 
PMA Calbiochem, Darmstadt, Germany 
P-nitrophenyl 
N-acetyl-β-D-glucosaminide Sigma-Aldrich, Munich, Germany 
Recombinant mouse IL-3 RD systems, Wiesbaden-Nordenstadt, Germany 
RPMI 1640 +L-glutamine GIBCO, Carlsbad, Germany 
SCF Peprotech, Tebu-bio, Rocky Hill, NJ, USA 
Thapsigargin Invitrogen, Karlsruhe, Germany 
TRAM-34 Sigma-Aldrich, Munich, Germany 
Tris base Sigma-Aldrich, Munich, Germany 
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Triton X-100 Sigma-Aldrich, Munich, Germany 
Tyrode’s Salt Solution Sigma-Aldrich, Munich, Germany 
Wortmannin Sigma-Aldrich, Munich Germany 
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3.2. Animals 
 
All animal experiments were conducted according to the guidelines of the American Physiological 
Society as well as the German law for the welfare of animals and were approved by local 
authorities. 
 
For PI 3-kinase experiments 129/SvJ, 129/SvP2 mice were used. 
 
Generating of sgk1-/- mice and their wt littermates  
 
A conditional targeting vector was generated from a 7-kb fragment encompassing the entire 
transcribed region on 12 exons. The neomycin resistance cassette was flanked by two loxP sites 
and inserted into intron 11. Exons 4-11, which code for the sgk1 domain, were “floxed” by 
inserting a third loxP site into intron 3. Targeted R1 embryonic stem cells were transiently 
transfected with Cre recombinase. A clone with a recombination between the first and third 
loxP site (type I recombination) was injected into C57BL/6 blastocytes. Male chimeras were 
bred to 129/SvJ females. Heterozygous sgk1-deficient mice were backcrossed to 129/SvJ wild-
type mice for two generations and then intercrossed to generate homozygous sgk1–/– and 
sgk1+/+ littermates (Wulff et al. 1263-68). The animals were genotyped by PCR using standard 
methods. The study has been performed in 6-8 week-old female and male sgk1+/+ and sgk1-/- 
mice. 
 
Generating of sgk3-/- mice and their wt littermates 
 
The targeting strategy for disruption of the SGK3 gene involved removing parts of exons 10 
(which contains the ATP-binding site necessary for the catalytic activity of SGK3) and 11, 
deleting intron 10, and introducing an in-frame STOP codon into exon 11. Plasmid pNTK loxp 
(gift from Dr. S. Coughlin) was used to generate the targeting vector. Two mouse genomic 
fragments, containing exons 8-11 and exons 10-17, were amplified from 129X1/SvJ DNA by 
PCR and cloned into pCR4- TOPO and pCR-XL-TOPO (both Invitrogen, Carlsbad, California, 
USA) respectively and characterized by restriction enzymes. The exon 8-11-containing construct 
was used as a 5 template in a second round of PCR to generate a 2.6-kb exon 8-10 fragment with a 
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BamHI site added to the 5’ end and an MfeI site added to the 3’ end. This fragment was used as 
the short arm and was inserted into the BamHI/MfeI sites of the targeting vector. The 10-kb long 
arm fragment was generated by using the exon 10-17-containing construct as a template in a 
second round of PCR. A ClaI site was added to the 5’ end, and a STOP codon was added before 
the start of exon 11; a XhoI site was added to the 3’ end. This fragment was inserted into the 
ClaI/XhoI sites of the targeting vector. The targeting vector was linearized by digestion with XhoI, 
and electroporated into RW-4 embryonic stem cells (derived from 129X1/SvJ mice). G418- and 
gancyclovir-resistant clones were initially screened by PCR using oligonucleotide primers located 
inside and outside the targeted locus to confirm homologous recombination. Two positive clones 
were expanded and their genomic DNA analyzed by Southern blot analysis following digestion by 
MfeI. An external probe (a 2kb restriction fragment lying between exons 1 and 7) was used to 
verify correct targeting. The two positive clones were injected into C57BL/6 blastocysts and 
transferred into pseudopregnant females. Chimaeric males, identified by their agouti coat color, 
were mated with C57BL/6 females. To generate mice homozygous for the targeted allele, the 
resulting sgk3+/- males and females were interbred (McCormick et al. 4278-88). 
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3.3. Culture of bone marrow mast cells 
 
Mast cells were isolated from femoral bone marrow (BMMCs) of 6-8 week-old male and 
female mice and cultured for 4 weeks in RPMI 1640 containing 10% FBS, 1% 
penicillin/streptomycin, 20 ng/ml interleukin-3 and 100 ng/ml of the c-kit ligand stem cell 
factor. BMMC maturation was confirmed by flow cytometry (FACS Calibur, Becton 
Dickinson) using the following antibodies: phycoerythrin-labelled anti-FcεRI, 
allophycocyanin-labelled anti-CD117 and fluorescein-isothiocyanate-labelled anti-CD34. The 
cells were kept in culture 4-6 weeks prior to the experiments. BMMCs were sensitized with 
monoclonal mouse anti-dinitrophenyl IgE (anti-DNP IgE, 5-10 µg/ml per 1 x 106 cells) in 
culture medium and challenged acutely with antigen, dinitrophenyl-human serum albumin (Ag, 
DNP-HSA, 50 ng/ml). In experiments with PI 3-kinase inhibition, LY-294002 (10 µM) was 
added to the medium 30 min before IgE. 
 
3.4. Patch clamp  
 
Patch clamp experiments were performed at room temperature in voltage-clamp, fast-whole-
cell mode. BMMCs were continuously superfused by a flow system inserted into the dish. The 
bath was grounded via a bridge filled with NaCl Ringer solution, containing (in mM): 145 
NaCl, 5 KCl, 2 MgCl2, 1 CaCl2, 10 glucose, 10 HEPES/NaOH (pH 7.4). Borosilicate glass 
pipettes (2-4 MOhm tip resistance; GC 150 TF-10, Clark Medical Instruments, Pangbourne, 
UK) manufactured by a microprocessor-driven DMZ puller (Zeitz, Augsburg, Germany) were 
used in combination with a MS314 electrical micromanipulator (MW, Märzhäuser, Wetzlar, 
Germany). The currents were recorded by an EPC-9 amplifier (Heka, Lambrecht, Germany) 
using Pulse software (Heka) and an ITC-16 Interface (Instrutech, Port Washington, N.Y., 
USA). Whole-cell currents were determined as 10 successive 200-ms square pulses from a -35 
mV holding potential to potentials between -115 mV and +65 mV. The currents were recorded 
with an acquisition frequency of 10 kHz and 3 kHz low-pass filtered. 
 
The pipette solution contained (in mM): 140 K-gluconate, 5 KCl, 1.2 MgCl2, 2 EGTA, 1.26 
CaCl2 (pCa 7), 2 Na2ATP and 10 HEPES/KOH (pH 7.2) and was used in combination with 
NaCl Ringer bath solution. Where indicated DNP-HSA (50 ng/ml), the channel blocker 
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TRAM-34 (300 nM) and/or the Ca2+ ionophore ionomycin (1 µM) were added to the bath 
solution. 
 
For some experiments Ca2+-free Ringer was used that contained 1 mM EGTA. Where indicated 
the Ag DNP-HSA (50 ng/ml), the channel blockers clotrimazole (1.5 µM), apamin (500 nM) 
and iberiotoxin (100 nM), as well as the Ca2+ ionophore ionomycin (1 µM) were added to the 
bath solution. DNP-HSA, apamin and iberiotoxin were prepared as stock solutions in water, 
clotrimazole in ethanol and ionomycin in dimethyl sulfoxide (DMSO). The final concentration 
of DMSO and ethanol were 0.01% and 0.005%, respectively. 
 
The offset potentials between both electrodes were zeroed before sealing, and the potentials 
were corrected for liquid junction potentials as estimated according to Barry & Lynch (Barry 
and Lynch 101-17). The original whole-cell current traces are depicted without further filtering 
and currents of the individual voltage square pulses are superimposed. The applied voltages 
refer to the cytoplasmic face of the membrane with respect to the extracellular space. The 
inward currents, defined as flow of positive charge from the extracellular to the cytoplasmic 
membrane face, are negative currents and depicted as downward deflections of the original 
current traces. 
 
3.5. Measurement of intracellular Ca2+ 
 
Fluorescence measurements were carried out with an inverted phase-contrast microscope 
(Axiovert 100, Zeiss, Oberkochen, Germany). Cells were excited alternatively at 340 and 380 
nm and the light was deflected by a dichroic mirror into the objective (Fluar 40×/1.30 oil, 
Zeiss). Emitted fluorescence intensity was recorded at 505 nm and data acquisition was 
performed by using specialized computer software (Metafluor, Universal Imaging, 
Downingtown, PA). As a measure for the increase of cytosolic Ca2+ activity, the slope and peak 
of the changes in the 340/380 nm ratio were calculated for each experiment. 
 
BMMCs were sensitized with IgE (10 µg/ml) for 1 hour at 37°C and subsequently loaded with 
Fura-2/AM (2 µM) for 20 min at 37°C. Intracellular Ca2+ was measured prior to and following 
addition of DNP-HSA to IgE-sensitized BMMCs in the absence or presence of extracellular 
Ca2+.  
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For PI 3-kinase experiments BMMCs were pretreated with LY-294002 (10 µM) for 30 min at 
37° C or left untreated. The cells were then sensitized with IgE (10 µg/ml) for 1 hour at 37°C 
and subsequently loaded with Fura-2/AM (2.5 µM) for 20 min at 37°C. Intracellular Ca2+ was 
measured prior to and following addition of DNP-HSA to IgE-sensitized BMMCs in the 
absence or presence of extracellular Ca2+.  
 
Alternatively, changes in cytosolic Ca2+ were monitored in both control and LY-294002-treated 
BMMCs upon depletion of the intracellular Ca2+ stores. Experiments were carried out prior to 
and during exposure to nominally Ca2+-free solution. In the absence of Ca2+ the intracellular 
Ca2+ stores were depleted by inhibition of the vesicular Ca2+ pump by thapsigargin (1 µM).  
 
For intracellular calibration purposes, ionomycin (10 µM) was applied at the end of each 
experiment. Experiments were performed with Ringer solution containing (in mM): 125 NaCl, 
5 KCl, 1.2 MgSO4, 1 CaCl2, 2 Na2HPO4, 32 HEPES, 5 glucose, pH 7.4. To reach nominally 
Ca2+-free conditions, experiments were performed using Ca2+-free Ringer solution containing 
(in mM): 125 NaCl, 5 KCl, 1.2 MgSO4, 2 Na2HPO4, 32 HEPES, 5 EGTA, 5 glucose, pH 7.4. 
 
3.6. Measurement of β-hexosaminidase and IL-6 release 
 
Mature BMMCs (0.3 x 106 per well) were seeded in a 96-well plate in fresh medium with 10 
µg/ml anti-DNP IgE antibody for 1 hour or overnight. Afterwards cells were washed in 
Tyrode’s Salt Solution and challenged with DNP-HSA (50 ng/ml) or for positive control with 
100 ng/ml phorbol myristate ester (PMA) and 1 µM ionomycin for 15 min at 37°C. 20 µl 
supernatant and 20 µl of 2 mM p-nitrophenyl N-acetyl-β-D-glucosaminide diluted in 0.2 M 
citrate buffer, pH 4.5, were mixed and incubated for 2 hours at 37°C. The reaction was 
terminated by the addition of 60 µl 1M Tris buffer, pH 9.0, and the absorbance was measured 
at 405 nm in an ELISA microplate reader.  
 
The data are evaluated as the percent of the total release (0.1 % Triton X-100) corrected for 
spontaneous release.  
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The concentration of IL-6 released from mast cells, which were sensitized with 1 µg/ml IgE for 
6 hours at 37°C and then stimulated with DNP-HAS (50 ng/ml) for 30 min, 6 hours, or 24 
hours, was measured by ELISA according to the instructions of the manufacturer (BD 
Biosciences). 
 
3.7. Model of passive systemic anaphylaxis and measurement of histamine serum 
concentrations 
 
Mice were sensitized with 2 µg/1 g weight anti-DNP IgE by intraperitoneal application. The 
next day or after 5 hours, mice were challenged with either DNP-HSA (4.8 µg/1 g weight) or 
PBS. Body temperature was monitored before and each 1-7 min after Ag challenge with a 
BAT-10 type T thermocouple thermometer and a RET-3 rectal probe for mice (Physitemp 
Instruments; distributed by World Precision Instruments) using a Duo18 data recording system 
(World Precision Instruments) during the midportion of the light phase of the light cycle. Mice 
were placed with the tail raised and the vaseline-covered probe was inserted a standardized 
distance of 2 cm until a stable temperature reading was obtained. Baseline temperature was 
measured after habituating mice to rectal probe insertion. Ambient room temperature was 
23°C, and the animals were exposed to a 12-hours light and 12-hours dark cycle (7 a.m.–7 
p.m.). 
Data are expressed as a change in body temperature following treatment (∆°C). 
 
Thirty minutes after induction of an anaphylactic reaction, blood was taken for the analysis of 
histamine plasma concentration. Histamine was measured by ELISA according to the 
instructions of the manufacturer (IBL-Hamburg). 
 
3.8. Statistics  
 
Data are provided as means ± SEM, n represents the number of independent experiments. All 
data were tested for significance using Student’s unpaired two-tailed t-test, one sample t-test or 
ANOVA (Dunnets test), where applicable. Results with p<0.05 were considered statistically 
significant. 
27 
4. RESULTS 
 
BMMC growth and maturation  
 
BMMCs expressed CD117, CD34 and FcεRI, receptors, typically expressed by mast cells. No 
significant difference in receptor abundance was observed between BMMCs from SGK1 
knockout mice (sgk1-/-) and their wild-type littermates (sgk1+/+) (Fig. 1), as well as from SGK3 
knockout mice (sgk3-/-) and their wild-type littermates (sgk3+/+) (Fig. 3). 
 
The forward scatter in cultured mast cells from sgk1+/+ and sgk1-/- mice is shown in Fig. 2. The 
forward scatter was slightly but significantly smaller in sgk1-/- BMMCs than in sgk1+/+ 
BMMCs, pointing to a smaller volume of SGK1-deficient mast cells. 
 
No significant difference was observed in forward scatter in mast cells from sgk3+/+ and sgk3-/- 
mice. 
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Figure 1: Maturation of BMMCs from sgk1+/+ and sgk1-/- mice 
A. Original dot plots of CD34-, CD117- and FcєRI-positive BMMCs from sgk1+/+ and sgk1-/- mice. 
Numbers depict the percent of cells in the respective quadrants, acquired within the mast cell gate. 
B. Percentage of mast cells in primary culture. Mean percent (±SEM; n=6 individual BMMC cultures) 
of sgk1+/+ (closed bars) and sgk1-/- (open bars) BMMCs acquired within the mast cell gate.  
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Figure 2: Forward scatter in BMMCs from sgk1+/+ and sgk1-/- mice 
A. Overlaid original traces illustrating the forward scatter of cultured BMMCs from sgk1+/+ (black line) 
and sgk1-/- (grey line) mice. 
B. Arithmetic means (±SEM; n=14) of forward scatter (FSC) of cultured BMMCs in arbitrary units 
(a.u.), from sgk1-/- mice (open bars) and sgk1+/+ (closed bars). ** (p=0.004) indicates significant 
difference from sgk1+/+, two-tailed unpaired t-test. 
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Figure 3: Maturation of BMMCs from sgk3+/+ and sgk3-/- mice 
A. Original dot plots of CD34-, CD117- and FcєRI-positive BMMCs from sgk3+/+ and sgk3-/- mice. 
Numbers depict the percent of cells in the respective quadrant, acquired within the mast cell gate. 
B. Frequency of mast cells in primary culture. Mean percent (±SEM; n=6 individual BMMC cultures) 
of sgk3+/+ (open bars) and sgk3-/- (closed bars) BMMCs acquired within the mast cell gate. 
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4.1. Blunted Ag-induced Ca2+ entry in BMMCs upon PI 3-kinase inhibition 
 
BMMCs were sensitized with IgE (10 µg/ml) for 1 hour, washed and then stimulated with Ag. 
According to Fura-2 fluorescence experiments exposure of control BMMCs to Ag was 
followed by a sharp increase in cytosolic Ca2+ concentration. This effect was markedly reduced 
when the mast cells were pretreated with PI 3-kinase inhibitor LY-294002 (10 µM, 30 min). 
Correspondingly, the fluorescence ∆ratio (peak) and the slope of the ratio (∆ratio/time) upon 
stimulation with Ag were significantly smaller (p < 0.001) in BMMCs pretreated with LY-
294002 than in control cells (Fig. 4B). Stimulation of BMMCs with Ag in Ca2+-free solution 
allowed an estimate of Ca2+ release from intracellular stores (Fig. 4C). This release was not 
significantly different between LY-294002-treated and control cells (Fig. 4D). Interestingly, 
basal free Ca2+ concentration was significantly lower (fluorescence ratio 1.37±0.08, n=20) in 
LY-294002-treated IgE-sensitized BMMCs (10 µM, 30 min) than in control cells (fluorescence 
ratio 1.56±0.09, n=25).  
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Figure 4: Ag-induced increase of intracellular Ca2+ is blunted by PI 3-kinase inhibitor LY-294002 
A. Representative tracings showing the Fura-2 fluorescence ratios (340/380 nm) in Fura-2/AM loaded 
control and LY-294002 (10 µM)-treated BMMCs prior to and following acute addition of Ag. At the 
end of each experiment ionomycin (10 µM) was added for calibration. For quantification of the Ca2+ 
entry into BMMCs, the slope (delta ratio/ms, indicated by dash lines) and peak (delta ratio, indicated by 
ticks) were calculated following addition of Ag. 
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B. Mean (± SEM) of the peak value (left) and slope (right) of the change in Fura-2 fluorescence for 
control (n=25, open bars) and LY-294002-treated BMMCs (10 µM, n=20, closed bars) following 
addition of Ag to the bath solution. *** (p<0.001) indicates significant difference between both groups 
(two-tailed unpaired t-test). 
C. Representative tracing showing the Fura-2 fluorescence ratio before and after addition of Ag in the 
absence of extracellular Ca2+ in control (left) and LY-294002- treated (right) BMMCs. To maintain a 
Ca2+-free environment, EGTA (0.5 mM) was added to the Ca2+- free bath solution.  
D. Mean (± SEM) of the peak value (left) and slope (right) of the fluorescence ratio change for control 
(n=6, open bars) and LY-294002-treated (10 µM, n=5, closed bars) BMMCs upon stimulation with Ag 
in a Ca2+-free solution. 
 
4.2. Influx of Ca2+ through SOCs is PI 3-kinase-dependent 
 
Further experiments were performed to determine, whether Ca2+ entry following Ca2+ store 
depletion, i.e. activation of SOCs, was similarly sensitive to PI 3-kinase inhibition. The stores 
were depleted by inhibition of the vesicular Ca2+-ATPase by addition of thapsigargin (1 µM) in 
Ca2+-free medium. Thapsigargin triggered a release of Ca2+ from intracellular stores, which 
was not significantly modified by LY-294002-treatment. Readdition of Ca2+ (1 mM) to the 
medium in the continued presence of thapsigargin led to an entry of Ca2+ through plasma 
membrane Ca2+ channels and to a subsequent increase of the fluorescence ratio (Fig. 5A). Both, 
peak and slope values were significantly lower in LY-294002-treated compared to control 
BMMCs (Fig. 5B). Thus, PI 3-kinase stimulates the influx of Ca2+ through the SOCs. 
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Figure 5: LY-294002 reduces the entry of extracellular Ca2+ through store-operated Ca2+ channels  
A. Representative tracings showing the Fura-2 fluorescence ratio (340/380 nm) in Fura-2/AM loaded 
control and LY-294002 (10 µM)-treated BMMCs. Experiments were carried out prior to and during 
exposure to nominally Ca2+-free bath solution. Where indicated, thapsigargin (1 µM) was added to the 
nominally Ca2+-free bath solution. Upon readdition of extracellular Ca2+ in the presence of thapsigargin 
the slope (delta ratio/time, indicated by dash lines) and peak (delta ratio, indicated by ticks) of the Fura-
2 fluorescence ratio change were calculated, reflecting the entry of Ca2+ through the SOCs. At the end 
of each experiment ionomycin (10 µM) was added for calibration purposes. 
B. Mean (± SEM) of the peak value (upper graph) and slope (lower graph) of the change in Fura-2 
fluorescence for control (n=25, open bars) and LY-294002-treated (10 µM, n=19, closed bars) BMMCs 
following readdition of extracellular Ca2+ in the presence of thapsigargin. * (p<0.05) indicates 
significant difference between both groups (two-tailed unpaired t-test). 
 
4.3. Ag-induced activation of Ca2+-activated K+ channels is PI 3-kinase-dependent 
 
Patch clamp experiments showed that the exposure of BMMCs to Ag was followed by 
activation of K+ currents, which were inhibitable by the specific KCa3.1 blocker TRAM-34 
(300 nM, Fig. 6A). Preincubation of the cells with LY-294002 (10 µM) for 30 min, prior to 
sensitization with IgE, resulted in a dramatic decrease of Ag-activated K+ conductance (Fig. 
6B, C).  
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Alternatively, Ca2+-activated K+ channel activation was induced by treatment of the BMMCs 
with the Ca2+ ionophore ionomycin (1 µM). Ionomycin-induced K+ currents were not 
significantly different between LY-294002-treated and non-treated cells (Fig. 6C) suggesting 
that the surface expression and maximal activity of the Ca2+-activated K+ channel did not differ 
between the two groups. This again suggests that LY-294002 decreased primarily the Ag-
stimulated Ca2+ signal. 
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Figure 6: Ag-induced K+ current in BMMCs is inhibited by LY-294002 
A, B. Mean I-V relationships (± SEM, n=5-7) in control (A, open symbols) or LY-294002-treated (10 
µM, 30 min, B, closed symbols) BMMCs prior to (Ringer, squares) or 3 min after stimulation with Ag 
(triangles) and then after inhibition by 300 nM TRAM-34 (A, Ag + TRAM-34, open circles). 
C. Mean whole-cell conductance (± SEM, n=5-7) in control (open bars) and LY-294002-treated (closed 
bars) BMMCs as recorded in (A, B) prior to (Ringer) and after stimulation with either Ag or ionomycin 
(1 µM). Data were calculated by linear regression between -55 and +5 mV. * (p<0.05) indicates 
significant difference from control cells in Ringer; # (p<0.05) indicates significant difference between 
control and LY-294002-treated cells (ANOVA). 
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4.4. β-hexosaminidase release is inhibited by LY-294002 
 
Mast cell degranulation in response to IgE-mediated stimulation, measured by β-
hexosaminidase release, was significantly reduced in LY-294002-treated cells (Fig. 7), results 
confirming previous observations (Ali, Watson, and Osborne 103-05;Tkaczyk et al. 48474-84). 
 
 
Figure 7: Degranulation of Ag-stimulated BMMCs is inhibited by LY-294002  
Mean β-hexosaminidase release (± SEM, n=10 individual experiments) from control (open bar) and 
LY-294002-treated (closed bar) BMMCs stimulated for 15 min with Ag. Release in the supernatant was 
calculated as % of total cellular (0.1% Triton X-100) β-hexosaminidase. The stimulated β-
hexosaminidase release in each experiment was corrected for the spontaneous release. ** indicates 
significant difference between both groups (p<0.001; two-tailed unpaired t-test). 
 
4.5. Reduced Ag-induced Ca2+ entry into BMMCs from sgk1-/- mice  
 
In order to study the responses of sgk1-/- and sgk1+/+ BMMCs upon stimulation with Ag via the 
FcεRI, the BMMCs were incubated overnight with IgE (10 µg/ml), washed and then stimulated 
with DNP-HSA. 
 
According to Fura-2 fluorescence, IgE-dependent activation of BMMCs was followed by an 
increase of cytosolic Ca2+ concentration. The rate of increase was significantly larger in sgk1+/+ 
than in sgk1-/- BMMCs (Fig. 8A, B). Accordingly, the maximal fluorescence ∆ratio (peak) and 
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the slope of the ratio (∆ratio/time) upon stimulation with Ag were significantly smaller in sgk1-
/-
 BMMCs than in sgk1+/+ BMMCs (Fig. 8B). To further assess the effect of SGK1 on Ca2+ 
mobilization, the cells were stimulated with IgE and Ag in the absence of extracellular Ca2+ 
(Fig. 8C). The measured release from intracellular stores was not significantly different 
between the genotypes (Fig. 8D).  
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Figure 8: Ag induced Ca2+ entry into BMMCs from sgk1+/+ and sgk1-/- mice 
A. Representative tracings showing the ratio of 340/380 nm Fura-2 fluorescence in Fura-2/AM loaded 
BMMCs prior to and following acute addition of Ag. At the end of each experiment, ionomycin (10 
µM) was added for calibration. For quantification of the Ca2+ entry into the BMMCs, the slope (delta 
ratio/ms, grey line) and peak (delta ratio, dotted lines) were calculated following addition of Ag.  
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B. Mean (±SEM) of the peak (upper graph) and slope (lower graph) of the fluorescence ratio change for 
sgk1+/+ (n=8, closed bars) and sgk1-/- (n=9, open bars) BMMCs following stimulation with Ag. * 
(p<0.05) indicates significant difference between both groups (two-tailed unpaired t-test).  
C. Representative tracings showing the Fura-2 fluorescence ratio before and after addition of Ag in the 
absence of extracellular Ca2+ in Fura-2/AM loaded BMMCs. To reach a Ca2+-free environment, EGTA 
(0.5 mM) was added to the Ca2+-free bath solution.  
D. Mean (±SEM) of the peak value (left) and slope (right) of the fluorescence ratio change for sgk1+/+ 
(n=6, closed bars) and sgk1-/- (n=4, open bars) BMMCs upon stimulation with Ag in a Ca2+-free 
solution. 
 
4.6. Reduced Ag-induced Ca2+ entry into BMMCs from sgk3-/- mice 
 
In order to study the responses of sgk3-/- and sgk3+/+ BMMCs, the cells were sensitized with 
IgE (10 µg/ml) for 1 hour at 37°C and subsequently loaded with Fura-2AM (2 µM) for 20 min 
at 37°C. 
 
Increase of cytosolic Ca2+ in sgk3-/- cells stimulated with IgE and cognate Ag was impaired if 
compared to sgk3+/+ cells (Fig. 9A, B). To further assess the effect of SGK3 on Ca2+ 
mobilization, the cells were stimulated with IgE and Ag in the absence of extracellular Ca2+ 
(Fig. 9C). Under these conditions, the measured release of Ca2+ from the intracellular stores 
was not different between sgk3+/+ and sgk3-/- cells (Fig. 9D), thus the entry of extracellular Ca2+ 
was impaired in sgk3-/- BMMCs. 
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Figure 9: Ag induced Ca2+ entry into BMMCs from sgk3+/+ and sgk3-/- mice 
 
A. Representative original tracings showing the Fura-2 fluorescence ratio of 340 over 380 nm in Fura-
2/AM loaded BMMCs from sgk3+/+ and sgk3-/- mice prior to and following acute addition of Ag. At the 
end of each experiment, ionomycin (10 µM) was added for calibration. For quantification of the Ca2+ 
entry into the BMMCs, the slope (∆ ratio/ms) and peak (∆ ratio) were calculated following addition of 
Ag as indicated in the figure. 
B. Mean (± SEM) of the slope (left) and peak (right) of the fluorescence ratio change for sgk3+/+ (n = 9, 
open bars) and sgk3-/- (n = 8, closed bars) BMMCs following stimulation with Ag. * (p<0.05) and ** 
(p<0.01) indicate significant difference between both groups (two-tailed unpaired t-test).  
C. Representative original tracings showing the ratio of 340/380 nm Fura-2 fluorescence in Fura-2 
loaded sgk3+/+ and sgk3-/- BMMCs before and after addition of Ag in the absence of extracellular Ca2+. 
To reach a Ca2+-free environment, EGTA (0.5 mM) was added to the Ca2+-free bath solution.  
Mean (± SEM) of the slope (left) and peak value (right) of the fluorescence ratio change for sgk3+/+ (n = 
5, open bars) and sgk3-/- (n = 5, closed bars) BMMCs upon stimulation with Ag in a Ca2+-free solution. 
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4.7. Impairment of Ca2+-activated K+ currents and membrane hyperpolarization in 
sgk1-/- BMMCs upon IgE-dependent stimulation 
 
In patch clamp experiments Ag stimulation of sgk1-/- and sgk1+/+ BMMCs led to a rapid 
increase of K+-selective conductance which was dependent on the presence of extracellular 
Ca2+, inhibited by 1.5 µM clotrimazole (Fig. 10A-C) and not sensitive to apamin (500 nM) or 
iberiotoxin (100 nM, data not shown). The same current could be induced by Ca2+ ionophore 
ionomycin (1 µM, Fig. 10F). This current was thus carried by Ca2+-activated K+ channels, 
which have recently been identified as KCa3.1 (Shumilina et al. 8040-47) and are known to be 
activated following FcεRI cross-linking in human mast cells (Duffy et al. 4261-70;Duffy et al. 
1006-08). The current induced by Ag in sgk1-/- BMMCs was significantly smaller than in wild-
type cells (Fig. 10D, E), whereas treatment of the cells with ionomycin led to activation of the 
K+ channels to a similar extent in sgk1+/+ and sgk1-/- BMMCs (Fig. 10F, G). Thus, Ca2+-
activated K+ channels are similarly expressed and are similarly sensitive to activation by Ca2+ 
in sgk1+/+ and sgk1-/- BMMCs. Accordingly, the blunted activation by Ag results from 
decreased Ca2+ entry into sgk1-/-BMMCs. 
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Figure 10: Ca2+-activated K+ current in sgk1+/+ and sgk1-/- BMMCs upon IgE-Ag-induced 
stimulation 
A. Representative whole-cell currents from sgk1+/+ BMMCs elicited by 400 ms pulses ranging from -
115 to +65 mV in 20 mV increments from a holding potential of -35 mV. Currents were recorded in 
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standard NaCl bath solution prior to (control) and 2 min after stimulation with Ag. The dotted line 
indicates the zero current value. 
B. Mean I-V relationships (±SEM, n=5-11) in sgk1+/+ BMMCs prior to (control, closed triangles) or 3 
min after stimulation with Ag added either to Ca2+-free NaCl (Ag/-Ca2+, open squares) or 1 mM Ca2+-
containing standard NaCl bath solution (Ag/+Ca2+, closed circles). 
C. Mean whole-cell conductance in paired experiments (±SEM, n=5) as recorded in (B) prior to or 3 
min after stimulation with Ag added either to Ca2+-free NaCl or 1 mM Ca2+-containing standard NaCl 
bath solution and after inhibition with 1.5 µM clotrimazole. Data were calculated by linear regression 
between -95 and +45 mV. * indicates significant difference from respective value following addition of 
the Ag to Ca2+-containing NaCl bath (p<0.05; ANOVA). 
D. Mean I-V relationships (±SEM, n=11-13) of currents in sgk1+/+ (closed symbols) and sgk1-/- (open 
symbols) BMMCs prior to (control, triangles) or 3 min after (Ag, circles) stimulation with Ag (50 
ng/ml) added to standard NaCl bath solution.  
E. Mean whole-cell conductance (±SEM) of sgk1+/+ (closed bars) and sgk1-/- (open bars), as recorded in 
(D) prior to and after stimulation with Ag. Data were calculated by linear regression between -95 and 
+45 mV. ** (***) indicate significant difference from Ag-stimulated sgk1+/+ cells, (*** p<0.001, ** 
p<0.01; ANOVA). 
F. Mean I-V relationships (±SEM, n=9-12) of currents in sgk1+/+ (closed symbols) and sgk1-/- (open 
symbols) BMMCs prior to (control, triangles) or 2 min after (ionomycin, circles) stimulation with 
ionomycin (1 µM) added to standard NaCl bath solution. 
G. Mean whole-cell conductance (±SEM, n=9-12) of sgk1+/+ (closed bars) and sgk1-/- (open bars) 
BMMCs, as recorded in (F) prior to and after stimulation with ionomycin. Data were calculated by 
linear regression between -95 and +45 mV. *** (p<0.001) indicates significant difference from control 
sgk1+/+ cells, ## (p<0.01) indicates significant difference from control sgk1-/- cells, ANOVA. 
 
4.8. Impairment of Ca2+-activated K+ currents and membrane hyperpolarization in 
sgk3-/- BMMCs upon IgE-dependent stimulation 
 
The K+ currents of sgk3-/- and sgk3+/+   BMMCs upon receptor stimulation were measured in 
patch-clamp experiments (Fig. 11). Addition of Ag to the bath solution resulted in a rapid 
increase of a K+-selective conductance in sgk3+/+   cells and to a significantly lesser extent in 
sgk3-/- cells (Fig. 11). However, when the cells were stimulated with a Ca2+ ionophore 
ionomycin, no difference in measured K+ currents was detected between the genotypes (Fig. 
11C). This suggests that the surface expression and maximal activity of the Ca2+-activated K+ 
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channel did not differ between the two groups and SGK3 deficiency primarily decreased the 
Ag-stimulated Ca2+ entry. 
 
 
 
Figure 11: Ag-induced K+ currents are reduced in sgk3-/- BMMCs  
A. Representative whole-cell currents from sgk3+/+ (left) and sgk3-/- (right) BMMCs elicited by 200 ms 
pulses ranging from -115 to +65 mV in 20 mV increments from a holding potential of -35 mV. Currents 
were recorded in standard NaCl bath solution 3 min after stimulation with Ag. The dotted line indicates 
the zero current value. 
B. Mean I-V relationships (± SEM, n=7) in sgk3+/+ (open symbols) and sgk3-/- (closed symbols) 
BMMCs prior to (control, squares) and 3 min after stimulation with Ag (Ag, 50 ng/ml, triangles). 
C. Mean whole-cell conductance (± SEM) of sgk3+/+ (open bars) and sgk3-/- (closed bars) BMMCs as 
recorded in (B) prior to (control) and after stimulation with either Ag or ionomycin (1 µM). Data were 
calculated by linear regression between -55 and +5 mV. * (P<0.05) indicate significant difference 
between sgk3+/+ and sgk3-/- cells; ### (P<0.001) indicate significant difference from sgk3+/+ cells under 
control conditions and §§§ (P<0.001) indicate significant difference from  
sgk3-/- cells under control conditions (ANOVA). 
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Decreased Ca2+ entry in sgk+/+- and sgk3-/- BMMCs could result in decreased Ag-induced mediator 
release. To determine whether SGK1 and SGK3 deficiency influences mast cell degranulation, the 
release ß-hexosaminidase was measured in sgk1-/-, sgk3-/- and respective wild-type cells. 
 
4.9. Altered degranulation ability of Ag-stimulated sgk1-/- BMMCs 
 
We also tested the ability of sgk1+/+ and sgk1-/- BMMCs to undergo degranulation upon 
stimulation with Ag via the FcεRI receptor. BMMCs release β-hexosaminidase, an enzyme 
stored in mast cell granules. Without stimulation, the release was 8.5 ± 1.5% (n=5) in sgk1+/+ 
BMMCs and 7.9±1.4% (n=5) in sgk1-/- BMMCs, values not significantly different between 
genotypes. Activation by Ag (50 ng/ml) or by ionomycin (1 µM) and PMA (100 ng/ml) 
stimulated degranulation in both genotypes. The effect was, however significantly smaller in 
sgk1-/- BMMCs than in sgk1+/+ BMMCs (Fig. 12). The early Ag-induced release of IL-6 (30 min 
of stimulation with Ag) was also significantly blunted in sgk1-/- cells (Fig. 12B, left). However, 
no difference between the two genotypes was observed when the cells were stimulated with Ag 
for a longer time (6 or 24 hours; Fig. 12B, right). These data confirm that SGK1 is a critical 
component of the signaling cascade leading to release of mast cell mediators. 
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Figure 12: β-Hexosaminidase and IL-6 release from sgk1-/- and sgk1+/+ BMMCs 
A. Mean β-hexosaminidase release (±SEM; n=5 individual experiments) from cultured sgk1-/- BMMCs 
and their wild-type littermates stimulated for 15 min with 50 ng/ml Ag or 100 ng/ml PMA and 1 µM 
ionomycin. The stimulated β -hexosaminidase release in each experiment was corrected for the 
spontaneous release. ** (p<0.01) and * (p < 0.05), significant difference between genotypes, two-tailed 
unpaired t test. 
B. Mean IL-6 release (±SEM; n=3 individual experiments) from cultured sgk1-/-  BMMCs and their 
wild-type littermates sensitized for 6 hours with IgE and then stimulated either for 30 min with Ag (50 
ng/ml, left) or 6 hours, or 24 hours (right). Each experiment was performed in duplicate; *** (p<0.001), 
two-tailed un- paired t test. 
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4.10. Altered degranulation ability of Ag-stimulated sgk3-/-  BMMCs 
 
To determine whether SGK3 deficiency influences mast cell degranulation, the release of β-
hexosaminidase was measured in sgk3+/+ and sgk3-/- cells. As shown in Fig. 13, β-
hexosaminidase release was significantly reduced in sgk3-/- BMMCs. 
 
 
Figure 13: Degranulation of Ag-stimulated sgk3-/- and sgk3+/+ BMMCs 
Arithmetic means (± SEM, n=5 individual experiments) of β-hexosaminidase release from cultured 
sgk3-/- BMMCs (closed bars) and their wild-type littermates sgk3+/+ (open bars) stimulated for 15 
minutes with. Release in the supernatant was calculated as % of total cellular (0.1% Triton X-100 ) β-
hexosaminidase. The stimulated β-hexosaminidase release in each experiment was corrected for the 
spontaneous release. * indicates significant difference between genotypes (p<0.05; two-tailed unpaired 
t-test). 
 
4.11. Impaired acute response to anaphylaxis and decreased histamine serum 
concentrations in sgk1-/- mice 
  
Further studies have been performed to explore whether the impaired stimulation of Ca2+ entry 
into sgk1-/- BMMCs affects their in vivo function. To this end, a model for the passive systemic 
anaphylaxis has been tested in both sgk1+/+ and sgk1-/- mice. The mice were sensitized with 
anti-DNP IgE intraperitoneally. After overnight rest, they received Ag or saline as a control by 
intraperitoneal injection and body temperature was monitored over time. The measured drop in 
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body temperature following Ag treatment was reduced in sgk1-/- mice, thus pointing to an 
impairment of sgk1-/--deficient mast cell function in vivo (Fig. 14A, B).  
 
Serum histamine level measured 30 min after induction of the anaphylactic reaction was 
significantly lower in sgk1-/- mice (Fig. 14C). 
 
 
 
 
Figure 14: Systemic anaphylactic reaction in sgk1-/- and sgk1+/+ mice 
A. Arithmetic means (±SEM) of changes in body temperature (∆°C) of sgk1-/- mice (n=8, open squares) 
and their wild-type littermates sgk1+/+ (n=7, closed squares) following induction of anaphylaxis. Mice 
were given intraperitoneal anti-DNP IgE (2µg/g body weight) and challenged with 4,8 µg/g body 
weight DNP-HSA after overnight rest.  
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B. Arithmetic means (± SEM) of maximal changes in body temperature (∆°C) of sgk1-/- mice (n=8, open 
bars) and their wild-type littermates sgk1+/+ (n=7, closed bars) following induction of anaphylaxis. ** 
indicates significant difference between genotypes (p=0.002; two-tailed unpaired t-test). 
C. Serum histamine level 30 min after induction of anaphylaxis in sgk1-/- mice (open bars) and their 
wild-type littermates sgk1+/+ (closed bars). Data represent the results obtained from 3 mice and from 
each mouse 3 individual probes were analyzed. * indicates significant difference between genotypes. 
 
4.12. Impaired acute response to anaphylaxis in sgk3-/- mice 
 
To evaluate whether the observed alterations in sgk3-/- BMMCs were also relevant for mast cell 
function in vivo, we triggered passive systemic anaphylaxis in sgk3+/+ and sgk3-/- mice. The 
mice were sensitized with anti-DNP IgE intraperitoneally. After 5 hours rest, mice received Ag 
or saline as a control by intraperitoneal injection and body temperature was monitored over 
time. As shown in Fig. 15, the decrease in body temperature following Ag treatment was 
dramatically decreased in sgk3-/- mice, an observation indeed pointing to severe impairment of 
mast cell function in vivo. 
 
51 
 
Figure 15: Systemic anaphylactic reaction in sgk3+/+ and sgk3-/- mice 
A. Arithmetic means (± SEM) of changes in body temperature (°C) of sgk3-/- mice (n=5, closed squares) 
and their wild-type littermates sgk3+/+ (n=6, open squares) following induction of anaphylaxis. Mice 
were given intraperitoneally anti-DNP IgE (2µg/g body weight) and challenged with 4,8µg/g body 
weight DNP-HSA after 5 hours.  
B. Arithmetic means (± SEM) of maximal changes in body temperature (°C) of sgk3-/- mice (n=5, open 
bars) and their wild-type littermates sgk3+/+ (n=6, closed bars) following induction of anaphylaxis. * 
indicates significant difference between genotypes (p<0.05; two-tailed unpaired t-test). 
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5. DISCUSSION 
 
The present study reveals a role of PI 3-kinase in the regulation of ion channel activity and thus 
the function of mast cells. Our data proved the importance of PI 3-kinase by the facts, that, first, 
Ca2+ signaling in response to FcεRI cross-linking was dramatically reduced upon inhibition of PI 
3-kinase by LY294002. Second, the capacitative Ca2+ entry following store depletion, reflecting 
the activity of SOCs, was also sensitive to PI 3-kinase inhibition. Third, inhibition of PI 3-kinase 
abrogated IgE-mediated stimulation of Ca2+-activated K+ channels.  
 
In the RBL-2H3 mast cell line two distinct Ca2+ influx pathways, capacitative and receptor-
mediated, have been demonstrated. The latter, non-capacitative Ca2+ influx mechanism, was 
shown to be PIP3- sensitive (Ching et al. 14814-20). In our experiments, capacitative Ca2+ entry 
was also dependent on the activity of PI 3-kinase, though to a less extent than IgE-dependent Ca2+ 
response. The capacitative Ca2+ entry could be affected indirectly via the activity of Ca2+-
activated K+ channels. Mast cell Ca2+-activated K+ channels are important amplifiers of Ca2+ 
entry since their activation hyperpolarizes the cell membrane and thus provides the electrical 
driving force for Ca2+ influx through SOCs (Parekh and Penner 901-30). Recently KCa3.1 
channel has been shown to be critically important for the regulation of Ca2+ entry and mast cell 
degranulation in mouse BMMCs (Shumilina et al.). 
 
The present results show that ionomycin-dependent activation of mast cell Ca2+-activated K+ 
channels is not dependent on PI 3-kinase, which means that neither the number of functional 
K+ channels, nor their maximal activity is reduced upon PI 3-kinase inhibition. 
 
In theory, the PIP3-sensitive Ca2+ influx (that is independent of the filling state of internal Ca2+ 
stores) may precede capacitative Ca2+ entry. This Ca2+ influx together with the PI 3-kinase-
independent Ca2+ release from the internal stores then leads to the activation of Ca2+-activated 
K+ channels, with subsequent hyperpolarization of the cell membrane. Capacitative Ca2+ entry 
through SOCs would be enhanced by this hyperpolarization. The observed reduced IgE-
mediated activation of Ca2+-activated K+ channels in the presence of the PI 3-kinase inhibitor 
LY-294002 could thus result from an impaired influx of Ca2+ through PIP3-sensitive channels. 
A decreased activation of K+ channels, in turn, is expected to impair the entry of Ca2+ through 
SOCs. However, assessment of the initial capacitative Ca2+ entry (through SOCs) in the present 
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study was performed under conditions, where cytosolic Ca2+ activity was rather decreased and 
thus K+ channel activity presumably not stimulated. Thus, PI 3-kinase most probably directly 
regulates SOC surface expression or activity.  
 
A recent study performed on fetal liver-derived mast cells from STIM-1-deficient mice has 
shown that STIM-1, a sensor of Ca2+ in the ER and an activator of SOCs, is an essential 
positive regulator of mast cell activation (Baba et al. 81-88). SOC influx was suggested to be a 
key mechanism of Ca2+ entry active in these cells, since the sustained increase in intracellular 
free Ca2+ concentration after FcεRI stimulation was almost completely abrogated in Stim1-/- 
mast cells (Baba et al. 81-88). However, the residual Ca2+ influx measured in Stim1-/- cells 
could represent a SOC-independent pathway. SOC-independent, PIP3-sensitive Ca2+ influx 
mechanism has been demonstrated in platelets, Jurkat T cells (Johnson et al. 831-37) and RBL-
2H3 mast cells (Ching et al. 14814-20). The molecular identity of PIP3-sensitive Ca2+ entry 
system has not been identified. There is evidence that TRPC channels could represent this 
mechanism, since PIP3 activates TRPC6 and to a less extent TRPC3 in HEK293 cells stably 
expressing these channel isoforms (Tseng et al. 11701-08); 2004). Moreover, PI 3-kinase 
further promotes the activity of TRPV2 channels (Penna et al. 495-507), which were shown to 
be expressed in bone marrow derived mast cells (Stokes et al. 137-47).  
 
Ion channels expressed in RBL-2H3 cells are, however, clearly distinct from those expressed in 
mouse BMMCs. At rest, RBL-2H3 cells exhibit a strongly inwardly-rectifying K+ conductance 
carried by Kir2.1 channel (Wischmeyer, Doring, and Karschin 115-20;Wischmeyer, Doring, 
and Karschin 34063-68) which is absent in mouse BMMCs. On the other hand, Ca2+-activated 
K+ channels activated following FcεRI cross-linking in mouse BMMCs, have never been 
demonstrated electrophysiologically in RBL-2H3 cells.  
 
The present observations do not rule out a direct action of PI 3-kinase signaling on Ca2+-
activated K+ channels. In activated primary human CD4 T cells, activation of KCa3.1 was 
shown to be dependent on phosphatidylinositol-3 phosphate (PI(3)P) and inhibited by LY-
294002 and wortmannin (Srivastava et al. 3630-38;Srivastava et al. 146-54;Srivastava et al. 
665-75). Nucleoside diphosphate kinase B, a mammalian hisitidine kinase, was shown to 
function downstream of PI(3)P to activate KCa3.1 (Srivastava et al. 3630-38;Srivastava et al. 
146-54;Srivastava et al. 665-75). 
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PI 3-kinase activates PDK1, which in turn activates the three SGK and the three protein kinase 
B/Akt isoforms (Lang et al. 1151-78). 
 
We found distinct functional differences of mast cells in gene-targeted mice lacking SGK1(sgk1-/-) 
and their wild-type littermates (sgk1+/+), as well as in mice lacking SGK3 (sgk3-/-) and their wild-
type littermates (sgk3+/+). Deficiency of SGK1 and SGK3 blunts Ca2+ entry, the currents through 
Ca2+-activated K+ channels and degranulation. Most importantly, anaphylactic reaction was 
strongly impaired in sgk1-/- and sgk3-/- mice.  
 
It has been shown, that SGK1 increases the cell membrane abundance and activity of the Ca2+ 
channel TRPV5 (Embark et al. 203-12). It is conceivable that SGK1 has a similar stimulating 
effect on TRPV2. 
 
SGK1/SGK3-dependent Ca2+ entry affects the activation of the Ca2+-activated K+ channels 
following Ag exposure. The K+ channel activation following ionomycin is, however, similar in 
sgk1-/-, sgk3-/- and the correspondent wild-type BMMCs. Thus, SGK1 and SGK3 blunt the Ag-
induced activation of those channels largely by compromising Ca2+ entry with only little or no 
direct effect on those K+ channels.  
 
In other systems, SGK1 has been shown to activate a wide variety of different K+ channels 
(Baltaev et al. 26-33;Embark et al. 601-06;Embark et al. 203-12;Gamper et al. 625-34;Henke et al. 
194-99;Palmada et al. 629-34;Ullrich et al. 1090-99;Wärntges et al. 617-24;Yoo et al. 23066-
75;Yun et al. 2823-30).  
 
The present study does not rule out Ca2+-independent effects of SGK1 on K+-channels and other 
functions of mast cells. SGK1 may not only participate in the basic functions of mast cells, but as 
well in their regulation by hormones and mediators. SGK1 is genomically upregulated by 
glucocorticoids (Firestone, Giampaolo, and O'Keeffe 1-12), mineralocorticoids (Chen et al. 2514-
19;Naray-Fejes-Toth et al. 16973-78;Shigaev et al. F613-F619), 1,25-dihydroxyvitamin D3 
(1,25(OH)2D3) (Akutsu et al. 1127-39), cell shrinkage (Waldegger et al. 4440-45), gonadotropins 
(Alliston et al. 1934-49;Alliston et al. 385-95;Gonzalez-Robayna et al. 1283-300;Richards et al. 
223-54), and TGFß (Lang et al. 8157-62;Waldegger et al. 1081-88). The kinase is activated by 
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IGF1 and insulin through PI 3-kinase and PDK1 (Alessi et al. 6541-51;Alessi and Cohen 55-
62;Divecha, Banfic, and Irvine 3207-14;Gamper et al. 625-34;Kobayashi and Cohen 319-
28;Kotani et al. 2313-21;Park et al. 3024-33). Glucocorticoids rather suppress mast cell function 
(Andrade, Hiragun, and Beaven 7254-62;Collado-Escobar, Cunha-Melo, and Beaven 244-
50;Fushimi et al. 134-42;Krishnaswamy et al. 167-76;Matsuda et al. 1357-63;Mazingue, Dessaint, 
and Capron 65-77;Robin et al. 2719-26;Wershil et al. 1391-98), an effect which, according to the 
present observations, cannot be mediated by upregulation of SGK1.  
 
It has been shown on Xenopus oocyte system, that SGK3 stimulate the activity of further ion 
channels including the epithelial Na+ channel ENaC (Friedrich et al. 693-96;Palmada et al. 
G143-G150), the renal and cochlear Cl- channel complex ClC-Ka/barttin (Embark et al. 1918-
25) , the cell volume regulated Cl- channel ClC2 (Palmada et al. 1001-06), the cardiac voltage-
gated Na+ channel SCN5A (Boehmer et al. 1079-84), the cardiac K+ channels KCNE1/KCNQ1 
(Embark et al. 601-06) and HERG(Maier et al. 177-86), the voltage-gated K+ channels Kv1.3 
(Gamper et al. 625-34;Henke et al. 194-99;Warntges et al. 617-24), Kv1.5 (Ullrich et al. 1090-
99) and Kv4.3 (Baltaev et al. 26-33). 
 
SGK3 stimulates the activity of the Na+-glucose cotransporter SGLT1 (Dieter et al. 862-70) the 
glutamine transporter SN1 (Boehmer et al. 156-62), the glutamate transporters EAAT1 
(Boehmer et al. 1181-88), EAAT2 (Boehmer et al. 911-21), EAAT3 (Schniepp et al. 1442-49) 
and EAAT5 (Boehmer et al. 738-42), the dicarboxylate cotransporter NaDC-1 (Boehmer et al. 
998-1003), the creatine transporter CreaT (SLC6A8) (Shojaiefard, Christie, and Lang 742-46) 
and the Na+/K+-ATPase activity (Henke et al. 370-74). 
 
Basal intestinal glucose transport is decreased in SGK3 knockout mice (Sandu et al. 437-44). 
Similarly, intestinal transport is impaired in the SGK1/SGK3 double knockout mouse. The 
impaired intestinal nutrient uptake may contribute to the delayed growth of both SGK3 knockout 
mice (McCormick et al. 4278-88) and SGK1/SGK3 double knockout mice (Grahammer et al. R945-
R950). 
 
SGK3 has been shown in vitro to confer cell survival (Liu, Yang, and Songyang 1233-36;Xu et 
al. 699-705), an effect which may be related to the effect of SGK3 on Kv1.3 channel activity. 
In human embryonic kidney cells and Jurkat lymphocytes Kv1.3 is involved in the regulation 
56 
of cell proliferation (Gamper et al. 625-34;Lang et al. 147-57) and apoptosis (Gulbins et al. 
7661-66;Szabo et al. 20465-69;Lang et al. 147-57). The antiapoptotic effect has further been 
attributed in part to phosphorylation of transcription factors (Brunet et al. 952-65;Liu, Yang, 
and Songyang 1233-36;Xu et al. 699-705). Moreover, SGK3 has been shown to phosphorylate 
and thus inactivate Bad (Liu, Yang, and Songyang 1233-36;Xu et al. 699-705). Phosphorylated 
Bad binds to the chaperone 14-3-3 and is thus prevented from travelling to the mitochondria, 
where it triggers apoptosis (Lizcano, Morrice, and Cohen 547-57).  
 
As was expected, knockout of PDK1 is not compatible with the survival. Reduced expression 
of PDK1 in PDK1 hypomorphic mice results in remarkably decreased size of the animals. The 
size of sgk1-/- mice is, however, normal, indicating that SGK1 could be replaced by the other 
five PDK1-dependent SGK and protein kinase B/Akt isoforms. One of those kinases is 
apparently SGK3, given that growth is delayed in SGK3 knockout mice. Along those lines, 
PDK1-dependent transport regulation is not abrogated in sgk1-/- mice under control conditions. 
Apparently, SGK1 is not vital for housekeeping functions but is critically important under 
defined stress conditions. Thus, at least in theory, pharmacological inhibition of SGK1 may 
counteract allergic reactions without severe side effects. 
 
In conclusion, the present observation confirms the role of PI 3-kinase, SGK1 and SGK3 in the 
regulation of mast cell function. Our results define a critical role for PI 3-kinase in regulating 
mast cell Ca2+ entry, Ca2+-dependent K+ channel activation and degranulation upon IgE-
mediated stimulation. SGK1 and SGK3 are also important for the regulation of Ca2+ entry, 
Ca2+- activated K+ channel activation, and degranulation of mast cells upon IgE-Ag-dependent 
stimulation. IgE-dependent systemic anaphylactic response is markedly attenuated in mice 
lacking functional SGK1 or SGK3. Thus, the present observations disclose new regulators of 
mast cell function, which could aid the development of novel therapies for the treatment of 
allergic diseases and other mast cell-mediated diseases by means of mast cell ion channel 
modulation.  
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6. SUMMARY 
 
Mast cells play a central role in IgE-dependent allergic reactions including allergic rhinitis, 
asthma, anaphylactic shock and delayed hypersensitivity reactions. 
 
The mechanism of mediator secretion from mast cells in disease includes modulation of ion 
channel activity. Cross-linking of the mast cell IgE-receptor (FcεRI) by antigen leads to 
stimulation of Ca2+ entry with subsequent mast cell degranulation and release of inflammatory 
mediators. Ca2+ further activates Ca2+-activated K+ channels, which in turn provide the electrical 
driving force for Ca2+ entry. The phosphoinositol-3 (PI3)-kinase pathway plays a pivotal role in 
the stimulation of mast cells. Previous studies have shown, that PI 3-kinase is required for mast 
cell activation and degranulation. Kinases activated through the PI 3-kinase pathway include 
serum- and glucocorticoid-inducible kinases 1 (SGK1) and 3 (SGK3). The present study has been 
performed to elucidate whether PI 3-kinase participates in the regulation of mast cell Ca2+ and 
Ca2+-activated K+ channels, and whether PI 3-kinase-dependent modulation of those channels is 
involved in the regulation of mast cell function. Also we explored the role of SGK1 and SGK3 in 
mast cell function. 
 
To this aim the whole-cell patch clamp experiments and Fura-2 fluorescence measurements for 
determination of cytosolic Ca2+ concentration were performed in LY-294002-treated and 
untreated mouse bone marrow-derived mast cells (BMMCs). In response to FcεRI cross-linking, 
Ca2+ entry but not Ca2+ release from the intracellular stores was dramatically reduced upon 
inhibition of PI 3-kinase by LY294002. Ca2+ entry following readdition of Ca2+  after Ca2+-store 
depletion with thapsigargin was also decreased by LY-294002, pointing to inhibition of store-
operated channels (SOCs). Moreover, inhibition of PI 3-kinase abrogated IgE-mediated, but not 
ionomycin-induced stimulation of Ca2+-activated K+ channels. 
 
To explore the role of SGK1 and SGK3, mast cells have been isolated from bone marrow of 
SGK1 and SGK3 knockout mice (sgk1-/-, sgk3-/-) and their wild-type littermates (sgk1+/+, sgk3+/+). 
Forward scatter, as determined by FACS analysis, was significantly smaller in sgk1-/- than in 
sgk1+/+ BMMCs, pointing to a decrease in cell volume. There was no difference in forward 
scatter between sgk3-/- and sgk3+/+ BMMCs.  Upon Ag stimulation via the FcεRI receptor, Ca2+ 
entry but not Ca2+ release from intracellular stores was markedly impaired in sgk1-/-and sgk3-/- 
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BMMCs. The currents through Ca2+-activated K+ channels induced by Ag were significantly 
higher in sgk1+/+ and sgk3+/+ BMMCs than in sgk1-/- and sgk3-/- cells, respectively. Treatment 
of the cells with Ca2+ ionophore ionomycin (1 µM) led to similar activation of the K+ channels 
in all tested genotypes, indicating that the Ca2+-activated K+ channels are similarly expressed 
and sensitive to activation by Ca2+ in sgk1-/- and sgk3-/- BMMCs as in their wt littermates, and 
that blunted stimulation of Ca2+-activated K+ channels was secondary to decreased Ca2+ entry. 
Compared to wild-type mice, IgE-Ag-induced degranulation of sgk1-/- and sgk3-/- BMMCs was 
significantly blunted. The decrease in body temperature following Ag treatment, which reflects 
anaphylactic reaction, was dramatically reduced in sgk1-/- and sgk3-/- mice, pointing to impaired 
mast cell function in vivo.  
 
Thus, our observations disclose PI 3-kinase-dependent regulation of Ca2+- and Ca2+-activated 
K+ channels, which in turn participate in triggering mast cell degranulation. SGK1 and SGK3 
are critically important for the regulation of Ca2+ entry, Ca2+-activated K+ channel activation 
and degranulation of mast cells upon IgE-Ag-dependent stimulation 
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